NIDA Genetics Consortium (NGC)

What We Do:

The NIDA Genetics Consortium was created in 1999 and has several overarching missions:

• Identify human chromosomal regions containing genes and/or specific genes that confer susceptibility to drug addiction
• Create a repository for data (i.e., clinical information and biospecimens containing DNA) that are contributed by multiple studies, so as to permit pooling of data to maximize statistical power
• Generate a database on molecular genetics of drug use disorders and related phenotypes to provide controlled access for collaborative studies with the broader scientific community
• Establish a consortium of scientists who meet regularly and collaborate on projects

Research Interests:

NIDA has created a list of domains and their associated measures to help with the harmonization of data in the area of genetic studies.

• Genetics Data Harmonization
• NIDA Center For Genetic Studies (cell and DNA biorepository)
• Description of Studies in the NIDA Genetics Consortium

Policies for access and distribution of DNA and clinical data from NIDA-funded studies on the genetics of addiction vulnerability

• Distribution of genetic data and biomaterials from the NIDA Center for Genetic Studies
• NIDA Distribution Agreement
• Frequently Asked Questions About the NIDA Center for Genetic Studies: How to Access the Repository
• Frequently Asked Questions About the NIDA Genetics Consortium and All Human Genetic Studies at NIDA (including information on membership, sharing plans and consent forms)
• Frequently Asked Questions About the NIDA Clinical Trials Network studies within the NIDA Genetics Consortium

Members:

• Member Contact Information

Contact:

Any questions or concerns regarding the Human Genetics Consortium please contact Joni Rutter Ph.D.